CarriereArea stampaRelazioni con gli investitori
  1. Home
  2. Diagnostica di Laboratorio
  3. Molecular Diagnostics
  4. Molecular Diagnostics Systems
  5. VERSANT HCV Genotype 2.0 Products (LiPA)
Molecular Assays

VERSANT HCV Genotype 2.0 Products (LiPA)Designed to identify and correctly detect multiple genotypes and subtypes

VERSANT® HCV Genotype 2.0 Products (LiPA) provide improved accuracy in identification of HCV genotype and subtype data for optimal patient therapy. Improve your efficiency with fully automated strip processing and an integrated system from amplification to interpretation.

  • Improved efficiency—scalable strip processing automation: up to 48 tests with the Auto-LiPA 48; up to 10 tests with the Tendigo
  • Ease of use—fully automated strip processing requiring minimal hands-on time
  • Convenient Line Probe Assay (LiPA)* format—standardized, globally recognized LiPA format
  • Enhanced confidence in results—updated interpretation chart includes decreased number of undetermined subtypes and rare genotype/subtype patterns
1/2
Auto-LiPA 48 Instrument – High Volume

Auto-LiPA 48 Instrument - High Volume

Auto-LiPA 48 Instrument – High Volume
Tendigo Instrument – Low to Mid-volume
1/2

Features & Benefits

VERSANT® HCV Genotype 2.0 Products – a simple and standardized method for HCV genotype and subtype detection. Learn more about how your lab can benefit from VERSANT HCV Genotype 2.0 Products.

Line Probe Assay (LiPA) Automation
Multiple throughput options to fit needs and volume requirements of small to large labs.

 

Improved Genotype/Subtype Performance
Overall performance data is comparable to NS5b sequencing. Identifies all 6 genotypes and more than 19 different subtypes. It is the only commercially available assay able to detect 6 (c-l). The addition of HCV Core region data to the assay allows more accurate differentiation of subtypes 1a and 1b, and more accurate identification of Genotype 6 (subtypes c-l).

 

LiPA Scan HCV Interpretation Software
Provides automation of strip interpretation and thus reduces the chance of operator error.

 

One Step RT-PCR
Easy-to-use for increased laboratory efficiency with a simple, complete, 1-step RT-PCR kit that can be used on commonly available thermocyclers.

Processing Time

Reduces hands-on labor and accelerates test reporting with complete walk-away processing of VERSANT® LiPA strips.

Assay Performance Data***

 

 

Characteristic

Result after initial testing

Result after repeat testing

Amplification (% of samples successfully amplified)

97.80%

99.70%

Accuracy (% of samples with correct genotype)

99.30%

 

*** Internal Evaluation Studies: 325 HCV-positive samples (Genotypes 1-6, Viral Loads – 2,173 IU/mL – 8,700,000 IU/mL versus reference method of NS5b Sequencing)

Technical Specifications

Hardware:
Auto-LiPA 48 Genotyping Instrument (Strip Processor)
Tendigo Genotyping Instrument (Strip Processor)

 

Reagents:
VERSANT® HCV Genotype 2.0 Assay (LiPA)
VERSANT® HCV Amplification 2.0 Kit (LiPA)
VERSANT® HCV Control 2.0 Kit (LiPA)

 

Software:
LiPA Scan HCV Interpretation Software

Auto-LiPA 48 instrument

Specification

Description

General

 

Display unit

Liquid Crystal Display with 2 rows of 16 digits

Keyboard

4-key membrane keyboard

Number of dispensing channels

6 (7th optional)

Capacity of reagent bottles

4 x 250 mL
2 x 500 mL
1 x 1000 mL
1 x 2000 mL  
1 x 2500 mL
1 x 3000 mL

Computer Interface

Serial RS 232 C, 9600 Baud, USB

Incubation temperature

Adjustable between 35°C and 65°C

Volume of reagent dispensed

250 - 3000 µL steps

Dispensing accuracy

Less than or equal to 10%

Cooling

Temperature < 30°C within 6 min

Power

 

Supply

Auto-sensing for settings
100 - 120 Volt and 220 - 240 Volt
50 or 60 Hz

Main fuses

2 x T 8A / 250V (Slow Blow)

Consumption

Max. 900 VA

Physical

 

External dimensions

Closed
Width: 804 mm/31"
Height: 460 mm/18"
Depth: 459 mm/18"

Open:
Width: 804.0 mm/31"
Height: 671.4 mm/26"
Depth: 510.6 mm/20"

Weight

47 kg

* CE-marked in the EU. FDA-approved in the U.S.

The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.